Physician profile
Stephen P Johnson
NPI 1972688505
$1,325.96
in general payments reported to CMS, 2019-2025
10 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2020: $15.63 · 2021: $292 · 2022: $263 · 2023: $68.02 · 2024: $359 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $580.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $655.36 | 2019-2024 | C3 Delivery System, Gore Viabahn Vbx Balloon Expandable Endo, Gore Tag Thoracic Branch Endoprosthesis |
| Inari Medical, INC. | $165.83 | 2021 | |
| Surmodics, INC. | $143.75 | 2022 | |
| Medtronic, INC. | $128.56 | 2022-2025 | Osteocool Rf Ablation System, Emprint, Kyphon Express II Kyphopak Tray |
| Philips North America LLC | $76.10 | 2022 | |
| Sirtex Medical INC | $61.10 | 2025 | Sir-Spheres Microspheres |
| Penumbra, INC. | $52.42 | 2019 | |
| Boston Scientific Corporation | $27.21 | 2022 | |
| Medtronic Vascular, INC. | $15.63 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.